Related Experiment Video
Updated: May 13, 2026

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
Published on: January 30, 2017
Elevated D-dimer on admission may predict poor prognosis in childhood influenza associated encephalopathy
Huizhen Wang1, Lingkong Zeng1, Xingfeng Cheng2
1Department of Neonatal Intensive Care Unit, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, , Huazhong University of Science and Technology, Wuhan, 430016, China.
Insights
Influenza-associated encephalopathy (IAE) often leads to poor outcomes. Elevated D-dimer levels are identified as a significant independent risk factor for predicting poor prognosis in children with IAE.
Area of Science:
- Pediatric Intensive Care
- Neurology
- Infectious Diseases
Background:
- Influenza-associated encephalopathy (IAE) is a severe neurological complication of influenza infection in children.
- Identifying risk factors for poor prognosis is crucial for timely intervention and improved patient outcomes.
Purpose of the Study:
- To determine the independent risk factors associated with a poor prognosis in children diagnosed with IAE.
- To evaluate the predictive value of D-dimer levels in assessing IAE prognosis.
Main Methods:
- Retrospective analysis of 56 children with IAE treated in a pediatric intensive care unit from January 2022 to December 2023.
- Univariate and binary logistic regression analyses were employed to identify risk factors for poor prognosis.
Main Results:
- Nearly half (46.4%) of the children experienced a poor prognosis.
- Elevated D-dimer levels were identified as an independent risk factor for poor prognosis (OR=1.440, P=0.023).
- A D-dimer level ≥1.18 mg/L FEU predicted poor prognosis with 65.4% sensitivity and 96.7% specificity.
Conclusions:
- IAE is associated with a high incidence of poor prognosis.
- D-dimer is a valuable biomarker for predicting poor prognosis in pediatric IAE.
- Further multicenter studies are warranted to validate these findings due to the study's limitations.
Abstract:
To determine the risk factors for poor prognosis of influenza-associated encephalopathy (IAE), 56 eligible children with IAE who were treated in the pediatric intensive care unit of Wuhan Children's Hospital from January 2022 to December 2023 were selected for retrospective analysis and grouped according to poor prognosis or not, and independent risk factors for poor prognosis were found by regression analysis. Results showed 26 children (26/30, 46.4%) had a poor prognosis. In the univariate analysis, the poor prognosis group compared with the clinically cured group showed a significant increase in the number of days of hospitalization (3.0 vs. 9.5 days, P < 0.001), high-sensitivity C-reactive protein (6.80 vs. 1.88 mg/L, P = 0.003), interleukin-6 (20.26 vs. 8.24 pg/mL, P = 0.001), interleukin-10 (11.75 vs. 4.72 pg/mL, P = 0.003), alanine aminotransferase (104.0 vs. 20.0 U/L, P = 0.011), aspartate azelotransferase (186.5 vs. 37.0 U/L, P = 0.003), serum albumin (37.99 vs. 40.76 g/L, P = 0.042), prothrombin time (13.2 vs. 11.4 s, P = 0.017), D-dimer (4.34 vs. 0.44 mg/L FEU, P < 0.001), peripheral blood CD19 B-cell count (35.11 vs. 32.75 cells/µL, P = 0.018), and cerebrospinal fluid chloride (126.82 vs. 125.50 mmol/L, P = 0.027) were statistically different in the above 11 indicators. After binary logistic regression analysis, it was concluded that D-dimer was an independent risk factor for poor prognosis (odds ratio = 1.440, 95% confidence interval 1.052-1.972, P = 0.023), and the area under the curve (95% confidence interval) was 0.802 (0.680-0.924), P < 0.001. When D-dimer was ≥ 1.18 mg/L FEU, the occurrence of poor prognosis was predicted with sensitivity and specificity of 65.4% and 96.7%, respectively. In conclusion, IAE has a high incidence of poor prognosis, in which D-dimer is a possible risk factor with discriminatory value in assessing the occurrence of poor prognosis. However, due to the limitations of retrospective single-center small sample size data, more confirmation from multicenter large sample size studies is needed in the future.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diphtheria
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

